Abbott · 1 day ago
Complaint Investigation Technician (First Shift)
Abbott is a global healthcare leader that helps people live more fully at all stages of life. The Complaint Investigation Technician will perform routine testing in a laboratory setting of medical devices associated with returns due to customer complaints, ensuring timely closure and compliance with established procedures.
BiotechnologyEmergency MedicineGeneticsHealth CareHealth DiagnosticsManufacturingMedicalMedical DeviceNutritionPharmaceutical
Responsibilities
Safely perform routine testing and receiving of returned products due to customer complaints and be able to document investigation activities clearly and accurately in a timely manner
Adhere to procedures and work instructions throughout
Be able to handle multiple tasks effectively and efficiently
Understand the priorities of investigation as outlined in the procedures and as assigned by the laboratory supervisor
Ensure that product returned is handled appropriately, investigated safely and accurately in a timely manner consistent with established procedures as failure to comply with requirements and regulations may lead to nonconformances resulting in FDA sanctions
Responsible for compliance with applicable Corporate and Divisional Policies and performing other duties as assigned by management
Qualification
Required
1-2 years of college or high school diploma with relevant experience
Good organizational, written, oral and interpersonal skills
Good Computer Skills. Basic mathematical skills are required
Preferred
Experience in controlled environment preferred
Benefits
Free medical coverage for employees via the Health Investment Plan (HIP) PPO
An excellent retirement savings plan with high employer contribution
Tuition reimbursement
The Freedom 2 Save student debt program
FreeU education benefit - an affordable and convenient path to getting a bachelor’s degree.
Company
Abbott
Abbott is a healthcare company that produces diagnostic kits, medical devices, nutritional products, and branded generic medicines.
Funding
Current Stage
Public CompanyTotal Funding
$6.79M2011-03-15Post Ipo Debt· $0.1M
2009-03-16Post Ipo Debt· $6.69M
1980-12-12IPO
Recent News
2025-12-31
Company data provided by crunchbase